Profile
NAMS VRTX REGN SGEN ALNY ARGX
Company Name NewAmsterdam Pharma Company N.V. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $1.74B $130.72B $61.65B $43.15B $35.25B $34.28B
Employees 0.07K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Dr. Michael Harvey Davidson FACC, Facp., M.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
NAMS VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 3
Quant Rating Sell Sell Buy Neutral Strong Sell Neutral
Trading
NAMS VRTX REGN SGEN ALNY ARGX
Last Close $15.86 $482.3 $576.72 $228.74 $243.27 $564.13
High 52 $26.61 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $15.16 $392.81 $557.31 $228.74 $143.31 $356.01
Price vs. 52 Week High -40.4 % -6.66 % -52.01 % 0 % -18.02 % -16.02 %
Price vs. 52 Week Low 4.62 % 22.78 % 3.48 % 0 % 69.75 % 58.46 %
Total Return
NAMS VRTX REGN SGEN ALNY ARGX
1 Month Return -32.22 % -3.54 % -22.6 % 0 % 4.39 % -1.12 %
3 Month Return -36.43 % 17.76 % -17.24 % 0 % 2.22 % -14.04 %
6 Month Return -9.99 % 1.29 % -42.27 % 0 % -12.69 % 6.99 %
9 Month Return -24.01 % -1.9 % -46.16 % 0 % -5.62 % 20.74 %
YTD Return -38.29 % 19.77 % -19.04 % 0 % 3.38 % -8.27 %
1 Year Return -16.96 % 21.31 % -38.4 % 0 % 59.62 % 47.38 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NAMS VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -239.45 % -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Growth
NAMS VRTX REGN SGEN ALNY ARGX
Asset Growth 149.1 % -0.87 % 14.15 % -1.21 % 10.71 %
Gross Profit Growth 257 % 10.25 % 8.23 % 22.93 % 26.81 %
Revenue Growth 257 % 11.66 % 8.27 % 24.65 % 22.97 %
Revenue 3 Year - 45.6 % -13.44 % 91.56 % 145.29 %
Revenue 5 Year - 163.93 % 82.78 % 215.48 % 769.33 %
Revenue 10 Year - 1632.15 % 429.43 % 494.04 % 2468.51 %
EBIT Growth -6.37 % -105.41 % -1.39 % 10.13 % 37.31 %
Net Income Growth -36.54 % -114.8 % 11.61 % 9.51 % 36.82 %
Net Income 3 Yeari Growth Per Share -23.8 % -122.89 % -46.47 % -763.59 % 69.96 %
Net Income 5 Yeari Growth Per Share -690.58 % -145.38 % 111.07 % -276.93 % 73.33 %
Net Income 10 Yeari Growth Per Share -690.58 % 33.84 % 1232.49 % -624.16 % 55.42 %
Operating Income Growth -6.37 % -105.41 % -1.39 % 10.13 % 37.31 %
Operating Cash Flow Growth (CFG) -12.28 % -113.93 % -3.78 % 9.07 % -107.98 %
Operating 3 Year CFG -18.54 % -118.65 % -38.85 % -147.99 % 98.81 %
Operating 5 Year CFG -399.66 % -131.3 % 84.11 % -195.86 % 97.46 %
Operating 10 Year CFG -399.66 % 12.43 % 517.51 % -2622.09 % 97.1 %
EPS Growth -19.07 % -114.8 % 10.39 % 10.81 % 38.64 %
EPS Diluted Growth -19.07 % -114.97 % 10.27 % 10.81 % 38.64 %
Book Value Per Share 128.71 % -6.59 % 11.76 % -9.83 % 129.53 %
Share Holder 3 Year Equity Growth Per Share 186.2 % 62.6 % 53.21 % 33.72 % -89.49 %
Share Holder 5 Year Equity Growth Per Share 4083.89 % 168.85 % 167.88 % 220.81 % -96.04 %
Share Holder 10 Year Equity Growth Per Share 4083.89 % 1265.7 % 1113.59 % 691.19 % -95.86 %
Dividend Per Share Growth - - - - -
Dividend 3 Year Growth Per Share - - - - -
Dividend 5 Year Growth Per Share - - - - -
Dividend 10 Year Growth Per Share - - - - -
Debt Growth 646.67 % 116.42 % 0.06 % -23.28 % -51.69 %
Free Cash Flow Growth -12.74 % -124.1 % -0.08 % 3.67 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
NAMS VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 99.96 % 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -26.85 % -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM -50.12 % -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM -22.18 % -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM 100 % -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM 138.1 % -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM -370.98 % -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM -33724.95 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM - 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM - 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM - 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM 6732.36 % 425.82 % 308.76 % 256.83 % 323.99 % 5106.8 %
Asset Turnover TTM 5.24 % 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM -1.6 -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM -1.61 -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 884.07 % 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM -333.46 % -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.42 % 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM -33724.95 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM -11.44 -165.4 17.14 -141.85 -827.74 -444.85
Price To Operating Cash Flows Ratio TTM -9.87 -266.09 13.96 -203.89 -4192.79 -531.16
Price Cash Flow Ratio TTM -9.87 -266.09 13.96 -203.89 -4192.79 -531.16
Income Statement (TTM)
NAMS VRTX REGN SGEN ALNY ARGX
Revenue $0.05B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0.05B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.24B $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.24B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -2.56 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
NAMS VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $0.11B $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $0.76B $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $0.06B $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.86B $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
NAMS VRTX REGN SGEN ALNY ARGX
Net Income $-0.24B $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.16B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 17.7
ABCL AbCellera Biologics Inc. 2.07
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.165
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1
ABPWW 0.0418
ABSI Absci Corporation 2.455
ABUS Arbutus Biopharma Corporation 3.11
ABVC ABVC BioPharma, Inc. 1.06
ABVX Abivax SA American Depositary Shares 5.62
ACAD ACADIA Pharmaceuticals Inc. 14.145
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4532
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.085
ACIU AC Immune SA 1.49
ACLX Arcellx, Inc. 56.74
ETFs With Exposure to NAMS
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.11052 113.04
GWX SPDR S&P International Small Cap ETF 0.059881 30.53
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 64.51
GURU Global X Guru Index ETF 1.11 44.74
DWAS Invesco DWA SmallCap Momentum ETF 0.299 71.34
FHLC Fidelity MSCI Health Care Index ETF 0.00523709 62.94
FAD First Trust Multi Cap Growth AlphaDEX Fund 0.06 121.055
FYC First Trust Small Cap Growth AlphaDEX Fund 0.31 63.78
FYX First Trust Small Cap Core AlphaDEX Fund 0.11 81.7745
SBIO ALPS Medical Breakthroughs ETF 0.017 24.24
SMMV iShares MSCI USA Small-Cap Min Vol Factor ETF 0.03682 39.325
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.11 24.5101
VINEX Vanguard International Explorer Fund Investor Shares 0.06 16.12
VGHAX Vanguard Health Care Fund Admiral Shares 0.08 72.11
VGHCX Vanguard Health Care Fund Investor Shares 0.08 171.03
IBBQ Invesco Nasdaq Biotechnology ETF 0.201 18.835
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.20068 5.4125
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.20068 5.402
STXK Ea Series Trust - Strive 2000 ETF 0.06 26
CUSS.L iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.00971 443.89
USFM.L UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-dis 0 2466.75
USUE.DE UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-acc 0 31.555
USFMDN.MX UBS (Irl) ETF Public Limited Company - MSCI USA Select Factor Mix UCITS ETF 0 382
WSML iShares MSCI World Small-Cap ETF 0.00917 23.82
Unlock